Pediatric brain tumors (PBT)

Brain and spinal cord tumors in children

#1

cause of cancer-related death in U.S. children ages 0–14

CBTRUS

6per 100,000

children and teens (0–19) diagnosed with a brain or spinal cord tumor each year

Neuro-Oncology

43,000

U.S. children and teens living with a brain or CNS tumor in 2025, cancerous and non-cancerous combined

Neuro-Oncology

Brain and spinal cord tumors are the leading cause of cancer-related death in children ages 0–14 in the U.S.

Source: CBTRUS · cbtrus.org

About 6 out of every 100,000 children and teens (ages 0–19) are diagnosed with a brain or spinal cord tumor each year.

Source: Neuro-Oncology · academic.oup.com/neuro-oncology

“Brain tumor” is not one disease but multiple diseases that each behave differently and are treated differently. Typical survival ranges from under 2 years to 20+ years depending on the exact type, so statistics should always be read type-by-type, not as one overall number.

Source: CBTRUS · cbtrus.org

Pilocytic astrocytoma is the most common brain tumor in children overall. It typically grows slowly and is highly curable, with 5-year survival above 95%.

Source: Neuro-Oncology · academic.oup.com/neuro-oncology

In 2025, almost 43,000 U.S. children and teens are living with a brain or central nervous system tumor, cancerous and non-cancerous combined.

Source: Neuro-Oncology · academic.oup.com/neuro-oncology

DIPG is the deadliest pediatric brain cancer.

Source: CBTRUS · cbtrus.org

Diffuse Intrinsic Pontine Glioma / Diffuse Midline Glioma

DIPG / DMG

An aggressive brainstem tumor with one of the lowest survival rates of any childhood cancer.

10–15%

of all childhood brain tumors

NCI PDQ

200–300

new U.S. cases diagnosed each year

NCI PDQ

9–11months

typical survival after diagnosis

PubMed Central

5–10years old

when most children are diagnosed

NCI

The tumor grows through the pons, the part of the brainstem that controls breathing and heart rate, so it cannot be safely removed with surgery.

Source: NCI PDQ

Radiation therapy is the standard treatment. It often helps symptoms for a while, but the cancer almost always returns.

Source: NCI PDQ

Despite decades of clinical trials, survival has not meaningfully improved, and adding chemotherapy has not extended survival beyond radiation alone.

Source: International DIPG/DMG Registry · dipgregistry.org

Medulloblastoma

Medulloblastoma

The most common cancerous brain tumor in children.

500

children diagnosed in the U.S. each year

PubMed Central

5–9years old

when most children are diagnosed, though it can happen at any age

PubMed Central

76%

of children are still alive 5 years after diagnosis

PubMed

Children whose cancer has spread within the brain or spine at diagnosis have lower survival, about 55%, compared with 80–85% for children whose cancer has not spread.

Source: NCI PDQ · cancer.gov

Treatment usually combines surgery, chemotherapy, and radiation to the brain and spine.

Source: NCI PDQ · cancer.gov

Medulloblastoma is four different diseases

Medulloblastoma is grouped into four molecular subtypes. Five-year survival differs enormously between them, which is why a single overall number understates the risk for some children and overstates it for others.

Subtype5-year survivalWhat drives the difference
WNTAbove 90%Often cited near 95–100%. The best outlook of any medulloblastoma subtype.
SHH65–75%Varies significantly by age and by whether the tumor carries a TP53 gene mutation.
Group 350–60%Falls below 50% when the tumor carries MYC gene amplification. The worst outlook of the four subtypes.
Group 475–90%Generally better than Group 3, but not as favorable as WNT.

Source: NCI PDQ · cancer.gov

Atypical Teratoid / Rhabdoid Tumor

ATRT

A rare, fast-growing brain tumor mostly seen in infants and very young children.

<100

children diagnosed in the U.S. each year

American Brain Tumor Association

90%+

of children are diagnosed before age 3, most often in their second year of life

PubMed Central

<1year

typical survival in many studies, especially for infants

PubMed Central

More than 95% of ATRT tumors are caused by the loss of a gene called SMARCB1 (also known as INI1).

Source: American Brain Tumor Association · abta.org

About 1 in 3 children with ATRT inherited the gene change that caused it. These children tend to be diagnosed earlier and have worse survival.

Source: American Brain Tumor Association · abta.org

Up to 40% of children already have cancer that has spread by the time they are diagnosed, and these children have lower survival than those whose cancer has not spread.

Source: NCBI PubMed Central · PMC12468553

Embryonal Tumor with Multilayered Rosettes

ETMR

A rare and aggressive brain tumor that mostly affects very young children.

25–36months

median age at diagnosis; most children are infants younger than 3

PubMed Central

<30%

of children survive 5 years, making it one of the deadliest childhood brain tumors

PubMed Central

90%

of ETMR tumors are caused by extra copies of a gene cluster called C19MC

PubMed Central

In some groups of patients, no children survived 5 years, and typical survival was measured in months rather than years, as low as about 7 months even with chemotherapy.

Source: NCBI PubMed Central · PMC12931075

About 90% of ETMR tumors are caused by extra copies of a gene cluster called C19MC, and others are linked to a gene called DICER1.

Source: NCBI PubMed Central

Chemotherapy is one of the few treatments consistently linked to better survival in ETMR, but there is still no standard treatment plan.

Source: NCBI PubMed Central

ETMR was only recognized as its own distinct type of brain tumor in 2016, so doctors are still learning about it. Before 2016 it was categorized under the broad umbrella of Central Nervous System Primitive Neuroectodermal Tumors (CNS-PNETs).

Source: NCBI PubMed Central

Traceability

Sources for this page

  • National Cancer Institute PDQ: Childhood Central Nervous System Embryonal Tumors Treatment · cancer.gov
  • American Brain Tumor Association: Atypical Teratoid/Rhabdoid Tumor (ATRT) · abta.org
  • NCBI PubMed Central: ATRT metastatic disease at diagnosis · PMC12468553
  • NCBI PubMed Central: ETMR outcomes · PMC12931075
  • Central Brain Tumor Registry of the United States (CBTRUS) · cbtrus.org
  • Neuro-Oncology (Society for Neuro-Oncology) · academic.oup.com/neuro-oncology
  • International DIPG/DMG Registry · dipgregistry.org

Statistics attributed to “NCI PDQ”, “PubMed”, or “PubMed Central” without a direct link above are accurate to the source documents provided by Rally. Article-level citation pending

The National Center for Childhood Cancer is the trusted source for childhood cancer statistics. Designed for journalists and policymakers, every statistic is fully sourced and includes the original source and year of the data to support accurate reporting, informed policy, and better decisions for children with cancer.